GlassScriptPhysician profile
Joe M Phillips
NPI 1902897945
$1,811.26
in general payments reported to CMS, 2019-2025
28 companies · $320 in 2025
The $320 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $133 · 2021: $102 · 2022: $383 · 2023: $435 · 2024: $235 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $990.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $990.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $250.87 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $219.78 | 2022-2025 | |
| Astellas Pharma US INC | $173.05 | 2019-2025 | Veozah, Myrbetriq |
| Evofem Biosciences, INC. | $164.16 | 2021-2025 | Phexxi, Solosec, Phexx |
| Coopersurgical, INC. | $135.37 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $107.13 | 2019-2025 | |
| Hologic Sales and Service, LLC | $96.93 | 2019-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Aptima |
| Biogen, INC. | $75.75 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $72.57 | 2022-2024 | |
| Meditrina | $65.06 | 2022-2023 | |
| Smith+Nephew, INC. | $60.74 | 2019-2025 | Pico 14 |
| Organon LLC | $55.84 | 2021-2025 | Nexplanon, Jada System |
| Daiichi Sankyo INC. | $49.84 | 2022-2023 | Injectafer |
| Sumitomo Pharma America, INC. | $45.01 | 2025 | Myfembree |
| Exeltis, USA INC. | $32.82 | 2022-2024 | Slynd |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $21.66 | 2025 | Intrarosa |
| Myovant Sciences INC. | $20.34 | 2022 | |
| Shield Therapeutics INC | $20.18 | 2024 | |
| Gynesonics, INC. | $19.21 | 2022 | |
| Kci USA, INC. | $16.92 | 2023 | Prevena |
| Boston Scientific Corporation | $14.78 | 2019 | |
| Aspira Women'S Health INC | $13.94 | 2024 | Ova1 |
| Amag Pharmaceuticals, INC. | $13.89 | 2019 | |
| Minerva Surgical, INC | $13.41 | 2024 | |
| Lupin INC. | $13.33 | 2019 | |
| Mallinckrodt Enterprises LLC | $13.28 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.82 | 2022 | |
| Ethicon US, LLC | $12.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.